![Stephen J. Moloney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Stephen J.
Moloney worked as a European Medical Director at Aspreva Pharmaceuticals Corp.
from 2005 to 2008.
He then worked as a Senior Medical Director at Shire Human Genetic Therapies, Inc. from 2008 to 2014.
In 2014, he became the Executive Medical Director at Aegerion Pharmaceuticals, Inc. until 2015.
From 2015 to 2017, he worked as the Vice President-Medical Affairs at PTC Therapeutics, Inc. He also worked as the Vice President-Global Medical Affairs at Strongbridge Biopharma Plc.
Dr. Moloney earned a doctorate degree from the University of Bristol.
Precedenti posizioni note di Stephen J. Moloney
| Società | Posizione | Fine |
|---|---|---|
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2017 |
| AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2015 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Direttore Tecnico/Scientifico/R&S | 01/02/2014 |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2008 |
| STRONGBRIDGE BIOPHARMA | Corporate Officer/Principal | - |
Formazione di Stephen J. Moloney
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
39
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Health Technology |
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for rare diseases | Health Technology |
